Top Markets
#1 Black Phoenix Black Phoenix +333.52%
#2 Islamic Coin Islamic Coin +158.10%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +21.05%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.65%
#6 DOVU DOVU +15.63%
#7 Palladium Network Palladium Network +8.75%
#8 Pons Pons +7.99%
#9 stake.link stake.link +7.92%
#10 Movement Movement +6.59%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Arno Therapeutics, Inc. Arno Therapeutics, Inc.

Arno Therapeutics, Inc.

ARNI
Rangering i aksjer #42094
Arno Therapeutics, Inc., headquartered in Flemington, New Jersey, operates as a... Arno Therapeutics, Inc., headquartered in Flemington, New Jersey, operates as a biopharmaceutical enterprise focused on discovering and advancing treatments for cancer and other severe health conditions. The company's developmental portfolio includes several key compounds: Onapristone, a type 1 anti-progestin hormone blocker, is currently undergoing Phase I/II clinical trials. This therapeutic is being investigated for its efficacy in treating various solid tumors, such as breast and endometrial cancers in post-menopausal women, and advanced castration-resistant prostate cancer in men. AR-12, an orally administered cancer therapy, has successfully completed Phase I clinical studies for solid tumors and hematological malignancies. Additionally, it is in pre-clinical development for potential applications against a range of microbial targets. AR-42, another innovative oral cancer treatment, is involved in a Phase I investigator-initiated clinical study, targeting both hematological malignancies and solid tumors. To support its research and development efforts, Arno Therapeutics has established licensing agreements with Invivis Pharmaceuticals, Inc., the Regents of the University of Minnesota, and the Ohio State University Innovation Foundation. The company also holds a co-development partnership with Leica Biosystems Newcastle Ltd.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$4.94K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Arno Therapeutics, Inc. (ARNI)

Kategori

Healthcare
Aksjeprishistorikk for Arno Therapeutics, Inc. (ARNI)
Høyeste sluttskurs: $0.00 den 2026-08-01

Laveste sluttskurs: $16.00 den 2008-06-01
Aksjeprishistorikk for Arno Therapeutics, Inc. fra 2008 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 0.00%
2025 63.64%
2024 -94.64%
2023 186,370.59%
2022 -99.95%
2021 -24.95%
2020 30.12%
2019 -10.49%
2018 -92.79%
2017 -84.04%
2016 -38.28%
2015 -47.11%
2014 -77.91%
2013 -27.61%
2012 -66.67%
2011 194.12%
2010 -49.00%
2009 -69.23%
2008 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -7.46%
KR